Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression

Lindsay P. Cameron, Charlie J. Benson, Lee E. Dunlap, David Olson

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Depression and anxiety disorders are debilitating diseases resulting in substantial economic costs to society. Traditional antidepressants often take weeks to months to positively affect mood and are ineffective for about 30% of the population. Alternatives, such as ketamine, a dissociative anesthetic capable of producing hallucinations, and the psychoactive tisane ayahuasca, have shown great promise due to their fast-acting nature and effectiveness in treatment-resistant populations. Here, we investigate the effects of N,N-dimethyltryptamine (DMT), the principle hallucinogenic component of ayahuasca, in rodent behavioral assays relevant to anxiety and depression using adult, male, Sprague-Dawley rats. We find that while DMT elicits initial anxiogenic responses in several of these paradigms, its long-lasting effects tend to reduce anxiety by facilitating the extinction of cued fear memory. Furthermore, DMT reduces immobility in the forced swim test, which is a characteristic behavioral response induced by many antidepressants. Our results demonstrate that DMT produces antidepressant and anxiolytic behavioral effects in rodents, warranting further investigation of ayahuasca and classical psychedelics as treatments for depression and post-traumatic stress disorder.

Original languageEnglish (US)
Pages (from-to)1582-1590
Number of pages9
JournalACS Chemical Neuroscience
Volume9
Issue number7
DOIs
StatePublished - Jul 18 2018

Fingerprint

N,N-Dimethyltryptamine
Banisteriopsis
Rats
Anxiety
Depression
Antidepressive Agents
Rodentia
Dissociative Anesthetics
Hallucinogens
Hallucinations
Anti-Anxiety Agents
Ketamine
Post-Traumatic Stress Disorders
Anxiety Disorders
Population
Fear
Sprague Dawley Rats
Assays
Economics
Data storage equipment

Keywords

  • ayahuasca
  • depression
  • DMT
  • N, N-dimethyltryptamine
  • post-traumatic stress disorder
  • psychedelic

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Cite this

Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression. / Cameron, Lindsay P.; Benson, Charlie J.; Dunlap, Lee E.; Olson, David.

In: ACS Chemical Neuroscience, Vol. 9, No. 7, 18.07.2018, p. 1582-1590.

Research output: Contribution to journalArticle

Cameron, Lindsay P. ; Benson, Charlie J. ; Dunlap, Lee E. ; Olson, David. / Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression. In: ACS Chemical Neuroscience. 2018 ; Vol. 9, No. 7. pp. 1582-1590.
@article{6e11e3c5c5a24d4ab23459fa6a86edda,
title = "Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression",
abstract = "Depression and anxiety disorders are debilitating diseases resulting in substantial economic costs to society. Traditional antidepressants often take weeks to months to positively affect mood and are ineffective for about 30{\%} of the population. Alternatives, such as ketamine, a dissociative anesthetic capable of producing hallucinations, and the psychoactive tisane ayahuasca, have shown great promise due to their fast-acting nature and effectiveness in treatment-resistant populations. Here, we investigate the effects of N,N-dimethyltryptamine (DMT), the principle hallucinogenic component of ayahuasca, in rodent behavioral assays relevant to anxiety and depression using adult, male, Sprague-Dawley rats. We find that while DMT elicits initial anxiogenic responses in several of these paradigms, its long-lasting effects tend to reduce anxiety by facilitating the extinction of cued fear memory. Furthermore, DMT reduces immobility in the forced swim test, which is a characteristic behavioral response induced by many antidepressants. Our results demonstrate that DMT produces antidepressant and anxiolytic behavioral effects in rodents, warranting further investigation of ayahuasca and classical psychedelics as treatments for depression and post-traumatic stress disorder.",
keywords = "ayahuasca, depression, DMT, N, N-dimethyltryptamine, post-traumatic stress disorder, psychedelic",
author = "Cameron, {Lindsay P.} and Benson, {Charlie J.} and Dunlap, {Lee E.} and David Olson",
year = "2018",
month = "7",
day = "18",
doi = "10.1021/acschemneuro.8b00134",
language = "English (US)",
volume = "9",
pages = "1582--1590",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression

AU - Cameron, Lindsay P.

AU - Benson, Charlie J.

AU - Dunlap, Lee E.

AU - Olson, David

PY - 2018/7/18

Y1 - 2018/7/18

N2 - Depression and anxiety disorders are debilitating diseases resulting in substantial economic costs to society. Traditional antidepressants often take weeks to months to positively affect mood and are ineffective for about 30% of the population. Alternatives, such as ketamine, a dissociative anesthetic capable of producing hallucinations, and the psychoactive tisane ayahuasca, have shown great promise due to their fast-acting nature and effectiveness in treatment-resistant populations. Here, we investigate the effects of N,N-dimethyltryptamine (DMT), the principle hallucinogenic component of ayahuasca, in rodent behavioral assays relevant to anxiety and depression using adult, male, Sprague-Dawley rats. We find that while DMT elicits initial anxiogenic responses in several of these paradigms, its long-lasting effects tend to reduce anxiety by facilitating the extinction of cued fear memory. Furthermore, DMT reduces immobility in the forced swim test, which is a characteristic behavioral response induced by many antidepressants. Our results demonstrate that DMT produces antidepressant and anxiolytic behavioral effects in rodents, warranting further investigation of ayahuasca and classical psychedelics as treatments for depression and post-traumatic stress disorder.

AB - Depression and anxiety disorders are debilitating diseases resulting in substantial economic costs to society. Traditional antidepressants often take weeks to months to positively affect mood and are ineffective for about 30% of the population. Alternatives, such as ketamine, a dissociative anesthetic capable of producing hallucinations, and the psychoactive tisane ayahuasca, have shown great promise due to their fast-acting nature and effectiveness in treatment-resistant populations. Here, we investigate the effects of N,N-dimethyltryptamine (DMT), the principle hallucinogenic component of ayahuasca, in rodent behavioral assays relevant to anxiety and depression using adult, male, Sprague-Dawley rats. We find that while DMT elicits initial anxiogenic responses in several of these paradigms, its long-lasting effects tend to reduce anxiety by facilitating the extinction of cued fear memory. Furthermore, DMT reduces immobility in the forced swim test, which is a characteristic behavioral response induced by many antidepressants. Our results demonstrate that DMT produces antidepressant and anxiolytic behavioral effects in rodents, warranting further investigation of ayahuasca and classical psychedelics as treatments for depression and post-traumatic stress disorder.

KW - ayahuasca

KW - depression

KW - DMT

KW - N, N-dimethyltryptamine

KW - post-traumatic stress disorder

KW - psychedelic

UR - http://www.scopus.com/inward/record.url?scp=85046412441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046412441&partnerID=8YFLogxK

U2 - 10.1021/acschemneuro.8b00134

DO - 10.1021/acschemneuro.8b00134

M3 - Article

VL - 9

SP - 1582

EP - 1590

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 7

ER -